Innate Pharma SA — All Filings
310 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
20-F
20-F/A
424B4
424B5
6-K
8-A12B
CERT
CORRESP
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-3
FWP
POS EX
S-8
SC 13D
SC 13D/A
SC 13G
SCHEDULE 13D/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 6-K | 6-K | 0001598599-24-000100 | Dec 20, 2024 | — |
| 6-K | 6-K | 0001598599-24-000098 | Dec 9, 2024 | — |
| 6-K | 6-K | 0001598599-24-000095 | Dec 6, 2024 | — |
| 6-K | 6-K | 0001598599-24-000094 | Dec 3, 2024 | — |
| 6-K | 6-K | 0001598599-24-000092 | Nov 20, 2024 | — |
| 6-K | 6-K | 0001598599-24-000089 | Nov 19, 2024 | — |
| 6-K | 6-K | 0001598599-24-000086 | Nov 13, 2024 | — |
| 6-K | 6-K | 0001598599-24-000083 | Nov 8, 2024 | — |
| 6-K | 6-K | 0001598599-24-000080 | Nov 7, 2024 | — |
| 6-K | 6-K | 0001598599-24-000078 | Oct 29, 2024 | — |
| 6-K | 6-K | 0001598599-24-000077 | Oct 15, 2024 | Oct 14, 2024 |
| 6-K | 6-K | 0001598599-24-000075 | Sep 30, 2024 | — |
| 6-K | 6-K | 0001598599-24-000072 | Sep 23, 2024 | — |
| 6-K | 6-K | 0001598599-24-000069 | Sep 12, 2024 | — |
| 6-K | 6-K | 0001628280-24-040187 | Sep 12, 2024 | Jun 30, 2024 |
| S-8 | S-8 | 0001598599-24-000067 | Sep 11, 2024 | — |
| 6-K | 6-K | 0001598599-24-000059 | Sep 9, 2024 | — |
| 6-K | 6-K | 0001598599-24-000057 | Sep 5, 2024 | — |
| 6-K | 6-K | 0001598599-24-000054 | Sep 4, 2024 | — |
| 6-K | 6-K | 0001598599-24-000051 | Jul 25, 2024 | — |
| 6-K | 6-K | 0001598599-24-000049 | Jun 18, 2024 | — |
| 6-K | 6-K | 0001598599-24-000047 | Jun 17, 2024 | — |
| 6-K | 6-K | 0001598599-24-000044 | Jun 4, 2024 | — |
| 6-K | 6-K | 0001598599-24-000042 | May 28, 2024 | — |
| 6-K | 6-K | 0001598599-24-000040 | May 24, 2024 | — |
| 6-K | 6-K | 0001598599-24-000039 | May 23, 2024 | — |
| 6-K | 6-K | 0001598599-24-000036 | May 15, 2024 | — |
| 6-K | 6-K | 0001598599-24-000034 | May 14, 2024 | — |
| 6-K | 6-K | 0001598599-24-000030 | May 7, 2024 | — |
| 6-K | 6-K | 0001598599-24-000028 | Apr 15, 2024 | — |
| 6-K | 6-K | 0001598599-24-000026 | Apr 15, 2024 | — |
| 6-K | 6-K | 0001598599-24-000023 | Apr 10, 2024 | — |
| 20-F | 20-F | 0001598599-24-000020 | Apr 4, 2024 | Dec 31, 2023 |
| 6-K | 6-K | 0001598599-24-000015 | Mar 21, 2024 | — |
| 6-K | 6-K | 0001598599-24-000013 | Mar 21, 2024 | — |
| 6-K | 6-K | 0001598599-24-000012 | Mar 19, 2024 | — |
| 6-K | 6-K | 0001598599-24-000010 | Mar 14, 2024 | — |
| 6-K | 6-K | 0001598599-24-000007 | Mar 6, 2024 | — |
| 6-K | 6-K | 0001598599-24-000006 | Mar 6, 2024 | — |
| 6-K | 6-K | 0001598599-24-000002 | Feb 21, 2024 | — |
| 424B5 | 424B5 | 0001628280-24-003513 | Feb 6, 2024 | — |
| 6-K | 6-K | 0001628280-24-003515 | Feb 6, 2024 | — |
| EFFECT | — | 9999999995-24-000128 | Jan 16, 2024 | — |
| 6-K | INNATE PHARMA S.A. 6-K | 0001157523-24-000054 | Jan 12, 2024 | — |
| CORRESP | — | 0001628280-24-001123 | Jan 11, 2024 | — |
| 6-K | INNATE PHARMA S.A. 6-K | 0001157523-24-000024 | Jan 5, 2024 | Jan 4, 2024 |
| 6-K | INNATE PHARMA 6-K | 0001157523-24-000012 | Jan 4, 2024 | — |
| 6-K | INNATE PHARMA S.A. 6-K | 0001157523-24-000013 | Jan 4, 2024 | — |
| UPLOAD | — | 0000000000-23-014072 | Dec 26, 2023 | — |
| F-3 | F-3 | 0001628280-23-042262 | Dec 20, 2023 | — |